Press Release | NeoGenomics Laboratories

January 22, 2015

NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014

December 16, 2014

NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program

October 30, 2014

NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014

October 23, 2014

NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton Tyrosin Kinase Inhibitors for Chronic Lymphocytic Leukemia

October 16, 2014

NeoGenomics Launches 315 Gene Next Generation Sequencing Test for Solid Tumor Discovery Profiling

September 29, 2014

NeoGenomics Appoints Robert J. Shovlin as Chief Operating Officer

September 24, 2014

NeoGenomics Schedules its Q3 2014 Earnings Release for October 30, 2014

August 22, 2014

NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients